Huakang Biomedical Holdings Company Limited (HKG:8622)

HKG:8622 Revenue

Huakang Biomedical Holdings Company had revenue of 12.33M CNY in the half year ending June 30, 2025, with 7.54% growth. This brings the company's revenue in the last twelve months to 25.77M, up 2.74% year-over-year. In the year 2024, Huakang Biomedical Holdings Company had annual revenue of 25.36M with 2.96% growth.

• Revenue (ttm): 25.77M CNY
• Revenue Growth: +2.74%
• P/S Ratio: 6.91
• Revenue / Employee: 283.19K CNY
• Employees: 91
• Market Cap: 195.18M HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	25.36M	730.00K	2.96%
Dec 31, 2023	24.63M	-701.00K	-2.77%
Dec 31, 2022	25.33M	-797.00K	-3.05%
Dec 31, 2021	26.13M	4.16M	18.94%
Dec 31, 2020	21.97M	-3.50M	-13.76%